Search Results - Giovanni Taccetti

Refine Results
  1. 1

    Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index by Vito Terlizzi, Chiara Castellani, Giovanni Taccetti, Beatrice Ferrari

    Published in Italian Journal of Pediatrics (2022-08-01)
    Get full text
    Article


  2. 2

    Can percussive intrapulmonary ventilation improve the efficacy of physiotherapy in children with cystic fibrosis? by Diletta Innocenti, Chiara Castellani, Eleonora Masi, Valeria Galici, Letizia Macconi, Giovanni Taccetti

    Published in Monaldi Archives for Chest Disease (2023-03-01)
    Get full text
    Article


  3. 3

    Management of pulmonary aspergillosis in children: a systematic review by Vito Terlizzi, Marco Antonio Motisi, Roberta Pellegrino, Luisa Galli, Giovanni Taccetti, Elena Chiappini

    Published in Italian Journal of Pediatrics (2023-03-01)
    Get full text
    Article


  4. 4

    Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives by Giovanni Taccetti, Michela Francalanci, Giovanna Pizzamiglio, Barbara Messore, Vincenzo Carnovale, Giuseppe Cimino, Marco Cipolli

    Published in Antibiotics (2021-03-01)
    Get full text
    Article


  5. 5

    Clinical features and outcomes of persons with cystic fibrosis and nocardia isolation: a systematic review by Vito Terlizzi, Tommaso Ballerini, Alice Castaldo, Daniela Dolce, Silvia Campana, Giovanni Taccetti, Elena Chiappini

    Published in BMC Pulmonary Medicine (2024-09-01)
    Get full text
    Article


  6. 6

    CFTR modulators response of S737F and T465N CFTR variants on patient-derived rectal organoids by Karina Kleinfelder, Paola Melotti, Anca Manuela Hristodor, Cristina Fevola, Giovanni Taccetti, Vito Terlizzi, Claudio Sorio

    Published in Orphanet Journal of Rare Diseases (2024-09-01)
    Get full text
    Article


  7. 7

    Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series by Vito Terlizzi, Giuseppe Fabio Parisi, Beatrice Ferrari, Chiara Castellani, Sara Manti, Salvatore Leonardi, Giovanni Taccetti

    Published in Children (2022-10-01)
    Get full text
    Article


  8. 8

    Ex vivo model predicted in vivo efficacy of CFTR modulator therapy in a child with rare genotype by Vito Terlizzi, Felice Amato, Chiara Castellani, Beatrice Ferrari, Luis J. V. Galietta, Giuseppe Castaldo, Giovanni Taccetti

    Published in Molecular Genetics & Genomic Medicine (2021-04-01)
    Get full text
    Article


  9. 9

    Elexacaftor/tezacaftor/ivacaftor and inflammation in children and adolescents with cystic fibrosis: a retrospective dual-center cohort study by Angela Pepe, Cristina Fevola, Daniela Dolce, Silvia Campana, Novella Ravenni, Giovanni Taccetti, Donatello Salvatore, Vito Terlizzi

    Get full text
    Article


  10. 10

    Comparison between Gibson–Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive... by Daniela Dolce, Cristina Fevola, Erica Camera, Tommaso Orioli, Ersilia Lucenteforte, Marco Andrea Malanima, Giovanni Taccetti, Vito Terlizzi

    Get full text
    Article


  11. 11

    Nocardia Isolation in People with Cystic Fibrosis and Non-CF Bronchiectasis: A Multicenter Italian Study by Laura Venditto, Daniela Dolce, Silvia Campana, Pamela Vitullo, Marco Di Maurizio, Cristina Fevola, Francesca Lucca, Giovanni Taccetti, Vito Terlizzi

    Published in Antibiotics (2025-03-01)
    Get full text
    Article


  12. 12

    Elexacaftor–Tezacaftor–Ivacaftor Therapy for Cystic Fibrosis Patients with The F508del/Unknown Genotype by Marika Comegna, Vito Terlizzi, Donatello Salvatore, Carmela Colangelo, Antonella Miriam Di Lullo, Immacolata Zollo, Giovanni Taccetti, Giuseppe Castaldo, Felice Amato

    Published in Antibiotics (2021-07-01)
    Get full text
    Article


  13. 13

    A Multicentre Italian Study on the Psychological Impact of an Inconclusive Cystic Fibrosis Diagnosis after Positive Neonatal Screening by Antonella Tosco, Diletta Marino, Sara Polizzi, Valentina Tradati, Rita Padoan, Claudia Giust, Benedetta Fabrizzi, Giovanni Taccetti, Lucia Merli, Vito Terlizzi

    Published in Children (2023-01-01)
    Get full text
    Article


  14. 14

    One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical... by Alice Castaldo, Alice Castaldo, Alice Castaldo, Monica Gelzo, Monica Gelzo, Paola Iacotucci, Annalisa Longobardi, Giovanni Taccetti, Vito Terlizzi, Vincenzo Carnovale

    Published in Frontiers in Molecular Biosciences (2024-01-01)
    Get full text
    Article


  15. 15

    Clinical and Genotypical Features of False-Negative Patients in 26 Years of Cystic Fibrosis Neonatal Screening in Tuscany, Italy by Giovanni Taccetti, Matteo Botti, Vito Terlizzi, Maria Chiara Cavicchi, Anna Silvia Neri, Valeria Galici, Gianfranco Mergni, Claudia Centrone, Diego G. Peroni, Filippo Festini

    Published in Diagnostics (2020-07-01)
    Get full text
    Article


  16. 16

    Non pathological sweat test, pancreatic insufficiency and Cystic Fibrosis: an unusual case in a child with F508del-duplication of exons 1–3 CFTR genotype by Vito Terlizzi, Cristina Fevola, Alice Castaldo, Selene Del Vespa, Daniela Dolce, Luca Scarallo, Karina Kleinfelder, Paola Melotti, Claudio Sorio, Giovanni Taccetti, Paolo Lionetti

    Published in BMC Pediatrics (2024-11-01)
    Get full text
    Article


  17. 17

    CRMS/CFSPID Subjects Carrying D1152H CFTR Variant: Can the Second Variant Be a Predictor of Disease Development? by Vito Terlizzi, Rita Padoan, Laura Claut, Carla Colombo, Benedetta Fabrizzi, Marco Lucarelli, Sabina Maria Bruno, Alice Castaldo, Paolo Bonomi, Giovanni Taccetti, Antonella Tosco

    Published in Diagnostics (2020-12-01)
    Get full text
    Article


  18. 18

    Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagno... by Chiara Bianchimani, Daniela Dolce, Claudia Centrone, Silvia Campana, Novella Ravenni, Tommaso Orioli, Erica Camera, Gianfranco Mergni, Cristina Fevola, Paolo Bonomi, Giovanni Taccetti, Vito Terlizzi

    Get full text
    Article


  19. 19

    Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy by Barry J Plant, Daniel Peckham, Pierre-Régis Burgel, Alan Smyth, Andreas Jung, Manfred Ballmann, Giovanni Taccetti, Harry Heijerman, Pavel Drevinek, Jochen G Mainz, Carsten Schwarz

    Published in BMJ Open Respiratory Research (2024-07-01)
    Get full text
    Article


  20. 20

    Untargeted Metagenomic Investigation of the Airway Microbiome of Cystic Fibrosis Patients with Moderate-Severe Lung Disease by Giovanni Bacci, Giovanni Taccetti, Daniela Dolce, Federica Armanini, Nicola Segata, Francesca Di Cesare, Vincenzina Lucidi, Ersilia Fiscarelli, Patrizia Morelli, Rosaria Casciaro, Anna Negroni, Alessio Mengoni, Annamaria Bevivino

    Published in Microorganisms (2020-07-01)
    Get full text
    Article


Search Tools: